Ground Swell Capital’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Ground Swell Capital’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$2K	Buy	+156	New	+$3.08K	﹤0.01%	2025

Other funds holding TBRA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TDC

Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ground Swell Capital's TBRA Position: Q3 2014 in Review

Ground Swell Capital opened a new position in Tobira Therapeutics, Inc. Common Stock (TBRA) in Q3 2014: 156 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #2025 among its holdings.

47 funds tracked by Wall St. Rank hold TBRA as of Q3 2014.

Ground Swell Capital held 156 shares of Tobira Therapeutics, Inc. Common Stock worth $2K as of Q3 2014.
Tobira Therapeutics, Inc. Common Stock was a new Ground Swell Capital position in Q3 2014.
Tobira Therapeutics, Inc. Common Stock made up ﹤0.01% of Ground Swell Capital's portfolio in Q3 2014, its #2025 holding.
47 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.